Health Care & Life Sciences » Biotechnology | Cynata Therapeutics Ltd.

Cynata Therapeutics Ltd. | Mutual Funds

Mutual Funds that own Cynata Therapeutics Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Funds SICAV - Pacific Fund
8,450,100
8.83%
4,857,031
0.34%
05/31/2018
Fidelity Japan Japan/Asia Growth Equity Mother Fund
497,445
0.52%
497,445
0.94%
12/11/2017

About Cynata Therapeutics

View Profile
Address
62 Lygon Street
Carlton Victoria (VIC) 3053
Australia
Employees -
Website http://www.cynata.com
Updated 07/08/2019
Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. It focuses on therapeutic stem cell platform technology. The company was founded on March 12, 2003 and is headquartered in Carlton, Australia.